Tetrahydro-4-quinolinamines identified as novel P2Y(1) receptor antagonists

Angel I Morales-Ramos1, John S Mecom, Terry J Kiesow

  • 1Department of Chemistry, Metabolic Pathways Centre for Excellence in Drug Discovery, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA. joseph.p.marino@gsk.com